Copyright Reports & Markets. All rights reserved.

Global Anti-Neoplastic Pharmaceutical Agents Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Hormones and Antagonists
      • 1.4.3 Microorganism Products
      • 1.4.4 Plant Products
      • 1.4.5 Antitumor Antibiotics
      • 1.4.6 Alkylating Agents
      • 1.4.7 Antimetabolites
      • 1.4.8 Natural Products
    • 1.5 Market by Application
      • 1.5.1 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2014-2025)
      • 1.5.2 Lung Cancer
      • 1.5.3 Bladder Cancer
      • 1.5.4 Breast Cancer
      • 1.5.5 Cervical Cancer
      • 1.5.6 Leukemia
      • 1.5.7 Gynecological Cancer
      • 1.5.8 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Anti-Neoplastic Pharmaceutical Agents Market Size
    • 2.2 Anti-Neoplastic Pharmaceutical Agents Growth Trends by Regions
      • 2.2.1 Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (2014-2025)
      • 2.2.2 Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Anti-Neoplastic Pharmaceutical Agents Market Size by by Players
      • 3.1.1 Global Anti-Neoplastic Pharmaceutical Agents Revenue by by Players (2014-2019)
      • 3.1.2 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio (CR5 and HHI)
    • 3.2 Anti-Neoplastic Pharmaceutical Agents Key Players Head office and Area Served
    • 3.3 Key Players Anti-Neoplastic Pharmaceutical Agents Product/Solution/Service
    • 3.4 Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2014-2019)
    • 4.2 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
    • 5.2 Anti-Neoplastic Pharmaceutical Agents Key Players in United States
    • 5.3 United States Anti-Neoplastic Pharmaceutical Agents Market Size by Type
    • 5.4 United States Anti-Neoplastic Pharmaceutical Agents Market Size by Application

    6 Europe

    • 6.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
    • 6.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Europe
    • 6.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type
    • 6.4 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application

    7 China

    • 7.1 China Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
    • 7.2 Anti-Neoplastic Pharmaceutical Agents Key Players in China
    • 7.3 China Anti-Neoplastic Pharmaceutical Agents Market Size by Type
    • 7.4 China Anti-Neoplastic Pharmaceutical Agents Market Size by Application

    8 Japan

    • 8.1 Japan Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
    • 8.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Japan
    • 8.3 Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Type
    • 8.4 Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
    • 9.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Southeast Asia
    • 9.3 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type
    • 9.4 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application

    10 India

    • 10.1 India Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
    • 10.2 Anti-Neoplastic Pharmaceutical Agents Key Players in India
    • 10.3 India Anti-Neoplastic Pharmaceutical Agents Market Size by Type
    • 10.4 India Anti-Neoplastic Pharmaceutical Agents Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size (2014-2019)
    • 11.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Central & South America
    • 11.3 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Type
    • 11.4 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Application

    12 International Players Profiles

    • 12.1 GlaxoSmithKline plc.
      • 12.1.1 GlaxoSmithKline plc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Anti-Neoplastic Pharmaceutical Agents Introduction
      • 12.1.4 GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
      • 12.1.5 GlaxoSmithKline plc. Recent Development
    • 12.2 F. Hoffmann-La Roche Ltd
      • 12.2.1 F. Hoffmann-La Roche Ltd Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Anti-Neoplastic Pharmaceutical Agents Introduction
      • 12.2.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
      • 12.2.5 F. Hoffmann-La Roche Ltd Recent Development
    • 12.3 Eli Lilly and Company
      • 12.3.1 Eli Lilly and Company Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Anti-Neoplastic Pharmaceutical Agents Introduction
      • 12.3.4 Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
      • 12.3.5 Eli Lilly and Company Recent Development
    • 12.4 Bristol-Myers Squibb Company
      • 12.4.1 Bristol-Myers Squibb Company Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Anti-Neoplastic Pharmaceutical Agents Introduction
      • 12.4.4 Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
      • 12.4.5 Bristol-Myers Squibb Company Recent Development
    • 12.5 Becton, Dickinson and Company
      • 12.5.1 Becton, Dickinson and Company Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Anti-Neoplastic Pharmaceutical Agents Introduction
      • 12.5.4 Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
      • 12.5.5 Becton, Dickinson and Company Recent Development
    • 12.6 Pfizer Inc.
      • 12.6.1 Pfizer Inc. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Anti-Neoplastic Pharmaceutical Agents Introduction
      • 12.6.4 Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
      • 12.6.5 Pfizer Inc. Recent Development
    • 12.7 Novartis AG
      • 12.7.1 Novartis AG Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Anti-Neoplastic Pharmaceutical Agents Introduction
      • 12.7.4 Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
      • 12.7.5 Novartis AG Recent Development
    • 12.8 AstraZeneca
      • 12.8.1 AstraZeneca Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Anti-Neoplastic Pharmaceutical Agents Introduction
      • 12.8.4 AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
      • 12.8.5 AstraZeneca Recent Development
    • 12.9 Gilead
      • 12.9.1 Gilead Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Anti-Neoplastic Pharmaceutical Agents Introduction
      • 12.9.4 Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2014-2019)
      • 12.9.5 Gilead Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Anti-neoplastic are the drugs that prevent growth of any abnormal tissue leading to cancer. The drugs pass into the human body and destroy cancerous cells. These drugs are also used in conjunction with surgery, radiotherapy and immunotherapy for solid tumors. The anti-neoplastic pharmaceutical agents are also known as cytotoxic agents .The changing lifestyle across the globe is increasing the chances of cancer which leads to high demand for the anti-neoplastic pharmaceutical agents from pharmaceutical companies.
      In 2018, the global Anti-Neoplastic Pharmaceutical Agents market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Anti-Neoplastic Pharmaceutical Agents status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-Neoplastic Pharmaceutical Agents development in United States, Europe and China.

      The key players covered in this study
      GlaxoSmithKline plc.
      F. Hoffmann-La Roche Ltd
      Eli Lilly and Company
      Bristol-Myers Squibb Company
      Becton, Dickinson and Company
      Pfizer Inc.
      Novartis AG
      AstraZeneca
      Gilead

      Market segment by Type, the product can be split into
      Hormones and Antagonists
      Microorganism Products
      Plant Products
      Antitumor Antibiotics
      Alkylating Agents
      Antimetabolites
      Natural Products

      Market segment by Application, split into
      Lung Cancer
      Bladder Cancer
      Breast Cancer
      Cervical Cancer
      Leukemia
      Gynecological Cancer
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Anti-Neoplastic Pharmaceutical Agents status, future forecast, growth opportunity, key market and key players.
      To present the Anti-Neoplastic Pharmaceutical Agents development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Anti-Neoplastic Pharmaceutical Agents are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now